Department of Medicine, Baylor College of Medicine, Houston, Texas.
Division of Cardiothoracic Surgery, Cardiovascular Research Center, Brown University Warren Alpert School of Medicine, Providence, RI.
Am J Med. 2024 Sep;137(9):810-817. doi: 10.1016/j.amjmed.2024.04.035. Epub 2024 May 8.
Dysfunction of the coronary microvasculature has become increasingly recognized as an important mechanism of myocardial ischemia in patients without obstructive coronary artery disease. The causes and management of coronary microvascular dysfunction remain poorly understood and are still largely based on extrapolation of epicardial coronary artery disease data. Quantification of myocardial blood flow and flow reserve have improved diagnosis, though important questions remain. In this review, we explain current understanding of the spectrum of pathophysiology of coronary microvascular dysfunction, summarize current diagnostic techniques to assess for coronary microvascular dysfunction, and appraise the limited data on management options specifically for patients with coronary microvascular dysfunction.
冠状动脉微血管功能障碍已越来越被认为是无阻塞性冠状动脉疾病患者心肌缺血的重要机制。目前对冠状动脉微血管功能障碍的病因和处理方法仍了解甚少,主要仍是基于对心外膜冠状动脉疾病数据的推断。尽管存在一些重要问题,但心肌血流和血流储备的量化仍改善了诊断。在这篇综述中,我们解释了目前对冠状动脉微血管功能障碍病理生理学谱的理解,总结了目前用于评估冠状动脉微血管功能障碍的诊断技术,并评价了专门针对冠状动脉微血管功能障碍患者的治疗选择的有限数据。